FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

ALMEIDA JOSE E
2. Issuer Name and Ticker or Trading Symbol

Walgreens Boots Alliance, Inc. [ WBA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

11/1/2019
(Street)

DEERFIELD, IL 60015
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  11/1/2019    A(1)    3485  A $0  7480  D 
 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ALMEIDA JOSE E
C/O WALGREENS BOOTS ALLIANCE, INC.
108 WILMOT ROAD
DEERFIELD, IL 60015
X



Signatures
/s/ Kelsey Chin, Attorney-in-Fact 11/4/2019
**Signature of Reporting Person Date


Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024 Plus de graphiques de la Bourse Walgreens Boots Alliance
Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024 Plus de graphiques de la Bourse Walgreens Boots Alliance

Actualités Walgreens Boots Alliance, Inc.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results
Jeudi 28 Mars 2024 ( il y a 4 minutes) • Business Wire
CLAIRE'S ANNOUNCES NATIONAL LAUNCH IN WALGREENS
Mardi 12 Mars 2024 ( il y a 2 semaines) • PR Newswire (US)
Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 6 Mars 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 6 Mars 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 6 Mars 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 6 Mars 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
Futures Pointing To Continued Weakness On Wall Street
Mardi 5 Mars 2024 ( il y a 3 semaines) • IH Market News
AMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on Disappointing Earnings, and Latest News
Mardi 5 Mars 2024 ( il y a 3 semaines) • IH Market News
Walgreens Boots Alliance Schedules Fiscal 2024 Second Quarter Earnings Announcement for March 28
Lundi 4 Mars 2024 ( il y a 3 semaines) • Business Wire
Walgreens First Community Pharmacy to Accept a Broad Array of Medicare Advantage Supplemental Benefits Online and in App
Mardi 27 Février 2024 ( il y a 4 semaines) • Business Wire
Walgreens First Community Pharmacy to Accept a Broad Array of Medicare Advantage Supplemental Benefits Online and in App
Mardi 27 Février 2024 ( il y a 4 semaines) • Business Wire
U.S. Stocks May Lack Direction Following Yesterday’s Modest Pullback
Mardi 27 Février 2024 ( il y a 4 semaines) • IH Market News